These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 10443589

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C, Eriksson A, Tellefors P, Ross SB, Stenfors C, Malmberg A.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):67-75. PubMed ID: 15363952
    [Abstract] [Full Text] [Related]

  • 23. Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo.
    Millan MJ, Gobert A, Audinot V, Dekeyne A, Newman-Tancredi A.
    Neuropsychopharmacology; 1999 Aug 19; 21(2 Suppl):61S-67S. PubMed ID: 10432490
    [Abstract] [Full Text] [Related]

  • 24. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS, Colpaert FC, Pauwels PJ.
    Br J Pharmacol; 1998 May 19; 124(2):283-90. PubMed ID: 9641544
    [Abstract] [Full Text] [Related]

  • 25. Stereoselective actions of the isomers of metitepine at 5-HT1D receptors in the guinea pig brain.
    Wilkinson LO, Hawkins LM, Beer MS, Hibert MF, Middlemiss DN.
    Neuropharmacology; 1993 Mar 19; 32(3):205-8. PubMed ID: 8474615
    [Abstract] [Full Text] [Related]

  • 26. The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM, Ham P, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Price GW, Roberts C, Routledge C, Selkirk J, Slade PD, Middlemiss DN.
    Ann N Y Acad Sci; 1998 Dec 15; 861():270-1. PubMed ID: 9928285
    [No Abstract] [Full Text] [Related]

  • 27. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
    Roberts C, Belenguer A, Middlemiss DN, Routledge C.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):175-80. PubMed ID: 9652357
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F, Guiblin AR, Jelley RA, Matassa VG, Reeve AJ, Hunt PA, Beer MS, Heald A, Stanton JA, Sohal B, Watt AP, Street LJ.
    J Med Chem; 1999 Feb 25; 42(4):677-90. PubMed ID: 10052975
    [Abstract] [Full Text] [Related]

  • 29. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Giles H, Lansdell SJ, Bolofo ML, Wilson HL, Martin GR.
    Br J Pharmacol; 1996 Mar 25; 117(6):1119-26. PubMed ID: 8882605
    [Abstract] [Full Text] [Related]

  • 30. Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs.
    Stenfors C, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun 25; 365(6):462-7. PubMed ID: 12070760
    [Abstract] [Full Text] [Related]

  • 31. Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.
    Davidson C, Stamford JA.
    Br J Pharmacol; 1995 Mar 25; 114(6):1107-9. PubMed ID: 7620698
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological characterisation of a cloned dog 5-HT1B receptor cell line.
    Beer MS, Heald MA, McAllister G, Stanton JA.
    Eur J Pharmacol; 1998 Oct 30; 360(1):117-21. PubMed ID: 9845281
    [Abstract] [Full Text] [Related]

  • 33. Effects of RU 24969 on serotonin release in rat brain cortex: further support for the identity of serotonin autoreceptors with 5-HT1B sites.
    Göthert M, Schlicker E, Fink K, Classen K.
    Arch Int Pharmacodyn Ther; 1987 Jul 30; 288(1):31-42. PubMed ID: 3662697
    [Abstract] [Full Text] [Related]

  • 34. Species differences in 5-HT autoreceptors.
    Price GW, Roberts C, Watson J, Burton M, Mulholland K, Middlemiss DN, Jones BJ.
    Behav Brain Res; 1996 Jul 30; 73(1-2):79-82. PubMed ID: 8788481
    [Abstract] [Full Text] [Related]

  • 35. (R)-(+)-2-[[[3-(Morpholinomethyl)-2H-chromen-8-yl]oxy]methyl] morpholine methanesulfonate: a new selective rat 5-hydroxytryptamine1B receptor antagonist.
    Berg S, Larsson LG, Rényi L, Ross SB, Thorberg SO, Thorell-Svantesson G.
    J Med Chem; 1998 May 21; 41(11):1934-42. PubMed ID: 9599242
    [Abstract] [Full Text] [Related]

  • 36. The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor.
    Middlemiss DN.
    J Pharm Pharmacol; 1985 Jun 21; 37(6):434-7. PubMed ID: 2862270
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA, Boot JR, Carney SL, Cohen ML, Colvin EM, Conway RG, Hardy CH, Lucaites VL, Nelson DL, Schenck KW, Tomlinson R, Wedley S.
    Eur J Pharmacol; 2001 Nov 30; 432(1):9-17. PubMed ID: 11734182
    [Abstract] [Full Text] [Related]

  • 38. Humanization of mouse 5-hydroxytryptamine1B receptor gene by homologous recombination: in vitro and in vivo characterization.
    Bonaventure P, Umans L, Bakker MH, Cras P, Langlois X, Luyten WH, Megens AA, Serneels L, Van Leuven F, Leysen JE.
    Mol Pharmacol; 1999 Jul 30; 56(1):54-67. PubMed ID: 10385684
    [Abstract] [Full Text] [Related]

  • 39. The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex.
    Hertel P, Nomikos GG, Svensson TH.
    Neuropharmacology; 1999 Aug 30; 38(8):1175-84. PubMed ID: 10462130
    [Abstract] [Full Text] [Related]

  • 40. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
    Verheggen R, Hundeshagen AG, Brown AM, Schindler M, Kaumann AJ.
    Br J Pharmacol; 1998 Aug 30; 124(7):1345-54. PubMed ID: 9723944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.